Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer
暂无分享,去创建一个
[1] Xiaorong Liu,et al. pyCHARMM: Embedding CHARMM Functionality in a Python Framework. , 2023, Journal of chemical theory and computation.
[2] K. Lindorff-Larsen,et al. The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate , 2023, bioRxiv.
[3] G. Mazzucchelli,et al. Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation , 2023, Nature Communications.
[4] I. Pogozheva,et al. Effects of calreticulin mutations on cell transformation and immunity , 2023, Journal of cellular and molecular medicine.
[5] S. Hubbard,et al. Structural basis of Janus kinase trans-activation , 2023, Cell reports.
[6] Nathan R. Kern,et al. CHARMM-GUI PDB Manipulator: Various PDB Structural Modifications for Biomolecular Modeling and Simulation. , 2023, Journal of molecular biology.
[7] J. Tavernier,et al. Mechanism of receptor assembly via the pleiotropic adipokine Leptin , 2022, bioRxiv.
[8] Cathy H. Wu,et al. UniProt: the Universal Protein Knowledgebase in 2023 , 2022, Nucleic Acids Res..
[9] C. Deane,et al. Membranome 3.0: Database of single‐pass membrane proteins with AlphaFold models , 2022, Protein science : a publication of the Protein Society.
[10] A. Pyle,et al. US-align: universal structure alignments of proteins, nucleic acids, and macromolecular complexes , 2022, Nature Methods.
[11] Jerry M. Parks,et al. AF2Complex predicts direct physical interactions in multimeric proteins with deep learning , 2022, Nature Communications.
[12] P. Lupardus,et al. Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation , 2022, Science.
[13] W. Im,et al. Comparative Molecular Dynamics Simulation Studies of Realistic Eukaryotic, Prokaryotic, and Archaeal Membranes , 2022, J. Chem. Inf. Model..
[14] G. Lukács,et al. Ins and outs of AlphaFold2 transmembrane protein structure predictions , 2022, Cellular and molecular life sciences : CMLS.
[15] D. Hassabis,et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models , 2021, Nucleic Acids Res..
[16] I. Rapado,et al. MPL S505C enhances driver mutations at W515 in essential thrombocythemia , 2021, Blood Cancer Journal.
[17] A. Lomize,et al. Spatial arrangement of proteins in planar and curved membranes by PPM 3.0 , 2021, Protein science : a publication of the Protein Society.
[18] Brandon Yushan Feng,et al. Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants , 2021, bioRxiv.
[19] D. Hassabis,et al. Protein complex prediction with AlphaFold-Multimer , 2021, bioRxiv.
[20] Douglas E. V. Pires,et al. A structural biology community assessment of AlphaFold2 applications , 2021, bioRxiv.
[21] A. Elofsson,et al. Improved prediction of protein-protein interactions using AlphaFold2 and extended multiple-sequence alignments , 2021, bioRxiv.
[22] J. Pei,et al. Human mitochondrial protein complexes revealed by large-scale coevolution analysis and deep learning-based structure modeling , 2021, bioRxiv.
[23] S. Ovchinnikov,et al. ColabFold: making protein folding accessible to all , 2022, Nature Methods.
[24] K. Kavukcuoglu,et al. Highly accurate protein structure prediction for the human proteome , 2021, Nature.
[25] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[26] J. Tucker,et al. The thrombopoietin receptor: revisiting the master regulator of platelet production , 2021, Platelets.
[27] W. Vainchenker,et al. Functional Consequences of Mutations in Myeloproliferative Neoplasms , 2021, HemaSphere.
[28] G. Hassink,et al. Growth Hormone Receptor Regulation in Cancer and Chronic Diseases , 2020, Frontiers in Endocrinology.
[29] S. Hubbard,et al. Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations , 2020, Science.
[30] S. Carillo,et al. MPL Mutations in Essential Thrombocythemia Uncover A Common Path of Activation with Eltrombopag Dependent on W491. , 2020, Blood.
[31] S. Hubbard,et al. Structural models of full-length JAK2 kinase , 2019, bioRxiv.
[32] D. Vertommen,et al. Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants. , 2019, Blood.
[33] J. Scheller,et al. Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy. , 2019, Cytokine & growth factor reviews.
[34] O. Silvennoinen,et al. The regulation of JAKs in cytokine signaling and its breakdown in disease. , 2019, Cytokine.
[35] W. Vainchenker,et al. The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applications , 2019, Expert review of hematology.
[36] M. Nguyen,et al. Structural Investigation of Human Prolactin Receptor Transmembrane Domain Homodimerization in a Membrane Environment through Multiscale Simulations. , 2019, The journal of physical chemistry. B.
[37] J. Babon,et al. The molecular details of cytokine signaling via the JAK/STAT pathway , 2018, Protein science : a publication of the Protein Society.
[38] H. Wallweber,et al. Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation , 2018, eLife.
[39] O. Bocharova,et al. Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor. , 2018, Biochimica et biophysica acta. General subjects.
[40] J. Tyner,et al. Gain-of-function mutations in granulocyte colony–stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation , 2018, The Journal of Biological Chemistry.
[41] A. Brooks,et al. The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects , 2018, Front. Endocrinol..
[42] W. Vainchenker,et al. Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis , 2017, Front. Endocrinol..
[43] P. Lupardus,et al. The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions , 2017, Front. Endocrinol..
[44] C. Pecquet,et al. The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin , 2017, Front. Endocrinol..
[45] Andrei L Lomize,et al. TMDOCK: An Energy-Based Method for Modeling α-Helical Dimers in Membranes. , 2017, Journal of molecular biology.
[46] Vijay S. Pande,et al. OpenMM 7: Rapid development of high performance algorithms for molecular dynamics , 2016, bioRxiv.
[47] B. L. de Groot,et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.
[48] Clifford Liongue,et al. Evolution of Cytokine Receptor Signaling , 2016, The Journal of Immunology.
[49] C. Pecquet,et al. Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms , 2016, Leukemia.
[50] S. Constantinescu,et al. His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor* , 2015, The Journal of Biological Chemistry.
[51] Alexander D. MacKerell,et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.
[52] Qingxin Li,et al. Solution structure of the transmembrane domain of the mouse erythropoietin receptor in detergent micelles , 2015, Scientific Reports.
[53] M. Waters,et al. Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes. , 2015, The Biochemical journal.
[54] A. Roitberg,et al. Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning. , 2015, Journal of chemical theory and computation.
[55] M. Waters,et al. JAK2 activation by growth hormone and other cytokines , 2015, The Biochemical journal.
[56] Sunhwan Jo,et al. CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..
[57] J. Olsen,et al. Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats. , 2014, Cytokine & growth factor reviews.
[58] Adam R. Johnson,et al. Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition , 2014, Proceedings of the National Academy of Sciences.
[59] Guillermo A. Gomez,et al. Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor , 2014, Science.
[60] W. Alexander,et al. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia , 2014, Growth factors.
[61] Marco Biasini,et al. lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests , 2013, Bioinform..
[62] C. Pecquet,et al. Tryptophan at the transmembrane–cytosolic junction modulates thrombopoietin receptor dimerization and activation , 2013, Proceedings of the National Academy of Sciences.
[63] Adrian Whitty,et al. Understanding cytokine and growth factor receptor activation mechanisms , 2012, Critical reviews in biochemistry and molecular biology.
[64] L. Johnson,et al. The structural basis for control of eukaryotic protein kinases. , 2012, Annual review of biochemistry.
[65] C. Brooks. Molecular mechanisms of prolactin and its receptor. , 2012, Endocrine reviews.
[66] C. Pecquet,et al. Orientation‐specific signalling by thrombopoietin receptor dimers , 2011, The EMBO journal.
[67] Wei Liu,et al. Functional impact of manipulation on the relative orientation of human prolactin receptor domains. , 2011, Biochemistry.
[68] D. Engelman,et al. Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[69] Patrick England,et al. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.
[70] V. Goffin,et al. New concepts in prolactin biology. , 2010, The Journal of endocrinology.
[71] Bo Yu,et al. Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)* , 2010, The Journal of Biological Chemistry.
[72] Alan E Mark,et al. Turning the growth hormone receptor on: Evidence that hormone binding induces subunit rotation , 2010, Proteins.
[73] S. Iida,et al. The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. , 2009, Blood.
[74] Jianpeng Ma,et al. CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..
[75] Jeffery B. Klauda,et al. CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. , 2009, Biophysical journal.
[76] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[77] A. Walker,et al. S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain. , 2008, Biochemistry.
[78] W. Im,et al. Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations , 2007, PloS one.
[79] D. Levy,et al. JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.
[80] S. Opella,et al. NMR Structural Studies of Interactions of a Small, Nonpeptidyl Tpo Mimic with the Thrombopoietin Receptor Extracellular Juxtamembrane and Transmembrane Domains* , 2007, Journal of Biological Chemistry.
[81] Harvey F. Lodish,et al. The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms* , 2006, Journal of Biological Chemistry.
[82] S. Gadd,et al. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. , 2006, Molecular endocrinology.
[83] H. Lodish,et al. Active Conformation of the Erythropoietin Receptor , 2006, Journal of Biological Chemistry.
[84] T. Okamoto,et al. Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[85] Michael W Parker,et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer , 2005, Nature Structural &Molecular Biology.
[86] S. Constantinescu,et al. Structural Requirements of the Extracellular to Transmembrane Domain Junction for Erythropoietin Receptor Function* , 2005, Journal of Biological Chemistry.
[87] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[88] K Henrick,et al. Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .
[89] J. Skolnick,et al. Scoring function for automated assessment of protein structure template quality , 2004, Proteins.
[90] Michael Feig,et al. MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. , 2004, Journal of molecular graphics & modelling.
[91] S. Constantinescu,et al. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. , 2003, Molecular cell.
[92] A. Kossiakoff,et al. Site2 binding energetics of the regulatory step of growth hormone–induced receptor homodimerization , 2003, Protein science : a publication of the Protein Society.
[93] W. Paul,et al. Molecular phylogeny within type I cytokines and their cognate receptors. , 2003, Immunity.
[94] A. Pizzey,et al. An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia , 2002, Oncogene.
[95] H. Lodish,et al. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[96] H. Lodish,et al. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. , 2001, Molecular cell.
[97] Ursula Klingmüller,et al. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor , 2001, Current Biology.
[98] A. Kossiakoff,et al. Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor , 2000, Nature Structural Biology.
[99] M. Waters,et al. Growth Hormone (GH)-independent Dimerization of GH Receptor by a Leucine Zipper Results in Constitutive Activation* , 2000, The Journal of Biological Chemistry.
[100] V. Broudy,et al. Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. , 1999, Blood.
[101] S. Anderson,et al. Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules* , 1999, The Journal of Biological Chemistry.
[102] I. Wilson,et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.
[103] Robert M. Stroud,et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.
[104] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[105] Bernard R. Brooks,et al. New spherical‐cutoff methods for long‐range forces in macromolecular simulation , 1994, J. Comput. Chem..
[106] Bernard R. Brooks,et al. Solvent-Induced Forces between Two Hydrophilic Groups , 1994 .
[107] H. Lodish,et al. Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[108] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[109] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[110] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[111] S. Watowich. The Erythropoietin Receptor: Molecular Structure and Hematopoietic Signaling Pathways , 2011 .
[112] B. Rost,et al. Critical assessment of methods of protein structure prediction (CASP)—Round 6 , 2005, Proteins.